IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Immunocellular Therapeutics

CUSIP: 452536905 | 2 institutional holders

Quarters

Q3 2015Q3 2014Q2 2014Q1 2014Q4 2013
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile